Page last updated: 2024-11-01

ondansetron and Rotator Cuff Injuries

ondansetron has been researched along with Rotator Cuff Injuries in 1 studies

Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.

Rotator Cuff Injuries: Injuries to the ROTATOR CUFF of the shoulder joint.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cho, CH1
Song, KS1
Min, BW1
Lee, KJ1
Ha, E1
Lee, YC1
Lee, YK1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Effect of a Multimodal Pain Regimen on Pain Control, Patient Satisfaction and Narcotic Use in Orthopaedic Trauma Patients[NCT02160301]Phase 40 participants (Actual)Interventional2017-11-30Withdrawn (stopped due to Insufficient infrastructure/funding for enrollment)
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

1 trial available for ondansetron and Rotator Cuff Injuries

ArticleYear
Multimodal approach to postoperative pain control in patients undergoing rotator cuff repair.
    Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA, 2011, Volume: 19, Issue:10

    Topics: Acetaminophen; Adult; Aged; Analgesia, Patient-Controlled; Analgesics; Arthroscopy; Cyclooxygenase 2

2011